Society of Vascular and Interventional Neurology / X
Jul 2, 2025, 16:51
Research Tuesday from SVIN: IV Thrombolysis in Cervical Artery Dissection—A Safer Path Home?
Society of Vascular and Interventional Neurology (SVIN) recentlyy posted on X:
”Research Tuesday: Retrospective study by Shu and Shadi Yaghi et al found that use of IV thrombolysis in cervical artery dissection related stroke improved odds of home DC without increased risk of ICH. Skim With SVIN”
Read the article from Journal of the American Heart Association here.
In a compelling retrospective study Shu, Shadi Yaghi, and colleagues evaluated outcomes of intravenous thrombolysis in patients with stroke due to cervical artery dissection.
Their findings reveal that IV thrombolysis significantly improves the odds of discharge to home without an associated increase in the risk of intracerebral hemorrhage (ICH).
These results offer important reassurance regarding the safety and functional benefit of thrombolysis in this unique stroke subtype—potentially reshaping decision-making in acute management.
Find more research breakthroughs in Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies